'Sh42b needed to commercialise anti-tick vaccine'
Research and further development of the vaccine needs to be amplified to full production for commercial levels.
PREMIUM Agric. & Environment
Research and further development of the vaccine needs to be amplified to full production for commercial levels. (Courtesy)
By NewVision Reporter
Journalists @NewVision
___________________
Authorities at Makerere University and Alfasan Uganda Ltd, a private pharma company, say they need at least sh42b to produce an anti-tick vaccine for commercialisation. Alfasan was